Korean J Pediatr Infect Dis.  2011 Dec;18(2):201-206.

Clinical Characteristics of Bacteremia in Children with Cancer

• Chang MS
• Sung KW
• Kim YJ

Abstract

PURPOSE
Bacteremia is one of the most common causes of morbidity and mortality in children with cancer. The aim of this study was to evaluate the clinical features of bacteremia in pediatric cancer patients.
METHODS
We retrospectively analyzed bacteremia episodes occurred in pediatric cancer patients at Samsung Medical Center from January 2008 to December 2010. We excluded bacteremia episodes after hematopoietic stem cell transplantation.
RESULTS
A total of 141 blood cultures were positive in 121 patients. Thirteen cultures due to contamination were excluded. For analysis, 128 bacteremia episodes in 108 children were included. Gram-positive organisms accounted for 46.9% (60/128) and gram-negative organisms for 53.1% (68/128). The source of bacteremia was identified in 21.1% of episodes. Bacteremia due to catheter related infection was observed in 9.4% of episodes (12/128 episodes) and gram-positive organisms were isolated in 75% of episodes (9/12). There were 10 cases (7.8%) of bacteremia associated with septic shock and gram-negative organisms were isolated in 80% of episodes (8/10). Relapses were documented within 30 days in 2 patients who cleared bacteremia which was confirmed after negative blood cultures. Mortality associated with bacteremia was not observed.
CONCLUSION
Continuous monitoring is needed to maintain the tailored strategies to manage pediatric cancer patients with neutropenic fever who are at high risk of developing bacteremia in each institution.

Keyword

Neutropenic fever; Bacteremia; Children

MeSH Terms

Bacteremia
Catheters
Child
Fever
Hematopoietic Stem Cells
Humans
Recurrence
Retrospective Studies
Shock, Septic

Reference

1. Biwersi C, Hepping N, Bode U, Fleischhack G, von Renesse A, Exner M, et al. Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health. 2009. 212:541–546.

2. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial blood-stream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003. 36:1103–1110.

3. Robinson JL, Rennie RP. Outcome of bacteremia and fungemia in paediatric oncology patients. Can J Infect Dis. 2002. 13:375–381.

4. Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2009. 31:623–629.

5. Swati M, Gita N, Sujata B, Farah J, Preeti M. Microbial etiology of febrile neutropenia. Indian J Hematol Blood Transfus. 2010. 26:49–55.

6. Kanamaru A, Tatsumi Y. Microbiological data for patients with febrile neutropenia. Clin Infect Dis. 2004. 39:S7–S10.

7. Blot F, Schmidt E, Nitenberg G, Tancrede C, Leclercq B, Laplanche A, et al. Earlier positivity of central-venous-versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol. 1998. 36:105–109.

8. Celkan T, Ozkan A, Apak H, Diren S, Can G, Yuksel L, et al. Bacteremia in childhood cancer. J Trop Pediatr. 2002. 48:373–377.

9. Velasco E, Byington R, Martins CS, Schirmer M, Dias LC, Goncalves VM. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect. 2004. 10:542–549.

10. Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, et al. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect. 2010. 138:1044–1051.